HeartCore to Host 'Listing on U.S. Stock Exchanges' Seminar on June 9, 2023 in Tokyo, Japan
NEW YORK and TOKYO, June 06, 2023 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (“HeartCore” or “the Company”), a leading software development company offering Customer Experience Management Platform (“CXM Platform”) and Digital Transformation (“DX”), will host a U.S. Exchange Listing seminar on June 9, 2023 in Tokyo, Japan.
The seminar will consist of a lecture and panel discussion by Keith Moore, CEO of Boustead Securities, LLC. HeartCore expects a myriad of Japanese companies to be in attendance, as the seminar will inform attendees of the realities of going public on U.S. Exchanges, including The Nasdaq Stock Market (“Nasdaq”) and the New York Stock Exchange (“NYSE”), in addition to an overview of its very successful Go IPO consulting service. As of May 31, 2023, HeartCore has received confirmation from 91 companies to be in attendance at the seminar.
Two of HeartCore’s Go IPO clients have now listed on Nasdaq, and HeartCore expects an additional six of its existing clients to commence trading on Nasdaq or the NYSE by the end of this year. HeartCore’s current fee structure consists of $500,000 and a success fee of approximately 3% of warrants from its client’s market capitalization.
“On behalf of HeartCore, I am pleased to host Boustead Securities’ CEO Keith Moore for our first ever U.S. Exchange listing seminar,” said CEO Sumitaka Yamamoto. “Given the recent, growing interest of Japanese companies to go public in the U.S., we want to capitalize on the opportunity by hosting this informative session where management team members will not only learn the benefits of being a public entity in the U.S. but can understand how HeartCore can be helpful with a historically strenuous process. Our Go IPO business pipeline continues to grow, and we’re encouraged by some of our bigger clients such as SBC Medical Group, which has agreed to merge with Pono Capital Two, Inc., a Nasdaq listed company. The transaction values SBC at $1.2 billion and HeartCore has been granted warrants with an approximate value of $32.4 million based on the SBC – Pono transaction value, which of course, will significantly benefit our top lie. Our increase in Q1 2023 revenue and our Q1 2023 profits, which surpassed all of 2022 profits came, in part, as a result of just two of our Go IPO companies successfully listing on Nasdaq. With six more clients expected to list on U.S. Exchanges in 2023 we anticipate a very strong year for our company.”
The seminar will be webcasted live on June 9, 2023 at 2:00 PM JST here.
About HeartCore Enterprises, Inc.
The Company does not render legal advice or perform accounting services, and will not act as an investment advisor or broker/dealer. Additionally, the Company does not provide the following services, among others: negotiation of the sale of a client’s securities; participation in discussions between a client and potential investors; assisting in structuring any transactions involving the sale of a client’s securities; pre-screening of potential investors; due diligence activities; and providing advice relating to valuation of or financial advisability of any investments in a client.
HeartCore Investor Relations Contact:
Solutions Showcase Session
UCaaS and MSPs: Driving Collaboration, Productivity, and Customer Experience
Generative AI Expo #TECHSUPERSHOW Expo Hall Open